Rafferty Asset Management, LLC Veracyte, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 90,427 shares of VCYT stock, worth $3.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

90,427

Previous 110,104 17.87%

Holding current value

$3.58 Million

Previous $2.39 Million 29.01%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.0 - $35.25 $413,217 - $693,614	-19,677 Reduced 17.87%	90,427 $3.08 Million
Q2 2024 Aug 13, 2024	SELL	$18.86 - $23.55 $3.74 Million - $4.67 Million	-198,455 Reduced 64.32%	110,104 $2.39 Million
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $3.13 Million - $4.34 Million	149,094 Added 93.5%	308,559 $6.84 Million
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $1.04 Million - $1.52 Million	-52,956 Reduced 24.93%	159,465 $4.39 Million
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $691,805 - $926,951	-30,981 Reduced 12.73%	212,421 $4.74 Million
Q2 2023 Aug 11, 2023	SELL	$20.96 - $26.99 $992,330 - $1.28 Million	-47,344 Reduced 16.28%	243,402 $6.2 Million
Q1 2023 May 11, 2023	BUY	$20.58 - $27.89 $185,590 - $251,512	9,018 Added 3.2%	290,746 $6.48 Million
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $978,140 - $1.91 Million	-63,889 Reduced 18.49%	281,728 $6.69 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $2.43 Million - $4.09 Million	146,636 Added 73.69%	345,617 $5.74 Million
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $398,331 - $761,084	-25,782 Reduced 11.47%	198,981 $3.96 Million
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $1.98 Million - $3.84 Million	90,313 Added 67.17%	224,763 $6.2 Million
Q4 2021 Feb 10, 2022	BUY	$36.09 - $53.79 $2.54 Million - $3.79 Million	70,418 Added 109.97%	134,450 $5.54 Million
Q3 2021 Nov 10, 2021	SELL	$35.62 - $52.97 $290,053 - $431,334	-8,143 Reduced 11.28%	64,032 $2.97 Million
Q2 2021 Aug 10, 2021	BUY	$32.94 - $56.62 $285,952 - $491,518	8,681 Added 13.67%	72,175 $2.89 Million
Q1 2021 May 10, 2021	BUY	$44.47 - $81.38 $2.13 Million - $3.9 Million	47,928 Added 307.9%	63,494 $3.41 Million
Q4 2020 Feb 10, 2021	SELL	$32.49 - $61.88 $955,368 - $1.82 Million	-29,405 Reduced 65.39%	15,566 $762,000
Q3 2020 Nov 13, 2020	BUY	$26.73 - $35.67 $623,610 - $832,181	23,330 Added 107.8%	44,971 $1.46 Million
Q2 2020 Aug 07, 2020	BUY	$19.49 - $28.11 $421,783 - $608,328	21,641 New	21,641 $561,000
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $878,730 - $1.64 Million	-54,478 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$20.78 - $29.99 $1.31 Million - $1.89 Million	-63,170 Reduced 53.69%	54,478 $1.52 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $703,854 - $912,032	29,487 Added 33.45%	117,648 $2.82 Million
Q2 2019 Aug 09, 2019	BUY	$22.1 - $28.56 $944,421 - $1.22 Million	42,734 Added 94.07%	88,161 $2.51 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $545,124 - $1.17 Million	45,427 New	45,427 $1.14 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Veracyte, Inc. Transaction History